To clarify the association of RAS with Wilms tumor risk, we selected single-nucleotide polymorphisms (SNPs) in the two most common diseased-related RAS genes, KRAS and NRAS, for analysis in a four-center hospital-based case-control study. This evidence concerns the gene NRAS and Wilms tumor.